Skip to content
2000
Volume 4, Issue 3
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

It has been established that patients with chronic kidney disease (CKD) suffer from frequent cardiovascular events. On the other hand, recent studies suggest that renal damage tends to worsen in patients with cardiovascular diseases (CVD). Although the mechanisms for the cardiorenal association are unclear, the presence of arteriosclerotic risk factors common to both CVD and CKD is important. In arteriosclerosis, vascular derangement progresses not only in the heart but also in the kidney. In addition, heart failure, cardiac catheterization and hesitation of medical treatments due to renal dysfunction may explain the progression of renal damage. Therefore, the goal of treatments is a total control of arteriosclerotic risk factors. Medication should be selected among agents with protective effects on both heart and kidney. It is important to always consider the presence of CKD for the treatment of the cardiovascular disease and strictly control the risk factors.

Loading

Article metrics loading...

/content/journals/ccr/10.2174/157340308785160543
2008-08-01
2025-10-31
Loading full text...

Full text loading...

/content/journals/ccr/10.2174/157340308785160543
Loading

  • Article Type:
    Research Article
Keyword(s): aldosterone; angiotensin II; ARB; CKD; hypertension
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test